DLBS1033

DRUG14 trials

Sponsors

Dexa Medica Group, Indonesia University, Duta Wacana Christian University, Universitas Sebelas Maret, RS H Adam Malik

Conditions

Acute Ischemic StrokeAcute Non-ST Elevation Myocardial InfarctionBenign Paroxysmal Positional Vertigo (Disorder)DiabetesDiabetes MellitusDiabetic NeuropathyDiabetic PolyneuropathyHealthy

Phase 1

Biological Half Life of DLBS1033 in Healthy Volunteers

CompletedNCT01905878

Indonesia UniversityHealthy Condition

Start: 2013-06-30End: 2013-12-31Updated: 2017-05-12

Phase 2

The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers

CompletedNCT01694537

Indonesia UniversityHealthy

Start: 2012-07-31End: 2012-12-31Updated: 2017-05-15

DLBS1033 for Acute Ischemic Stroke Patients

TerminatedNCT02133521

Dexa Medica GroupAcute Ischemic Stroke, Lacunar Anterior Circulation Infarct, Partial Anterior Circulation Infarct

Start: 2014-11-11End: 2023-04-21Updated: 2023-12-12

DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease

TerminatedNCT02145988

Dexa Medica GroupDiabetes, Peripheral Arterial Disease

Start: 2015-06-03End: 2018-07-31Updated: 2018-07-26

DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization

WithdrawnNCT02146664

Dexa Medica GroupAcute Non-ST Elevation Myocardial Infarction

Start: 2015-11-30End: 2018-03-31Updated: 2016-04-20

Effect of DLBS1033 After Primary PCI in Patients With STE-ACS

TerminatedNCT02976701

Dexa Medica GroupST Elevation Myocardial Infarction

Start: 2016-11-30End: 2023-03-31Updated: 2023-09-08

The Benefit of Add On DLBS1033 for Ischemic Stroke Patient

Duta Wacana Christian UniversityIschemic Stroke

Start: 2020-04-01End: 2020-08-31Target: 180Updated: 2020-06-11

The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy

Not yet recruitingNCT07475065

Universitas Sebelas MaretDiabetes Mellitus, Diabetic Polyneuropathy, Peripheral Nervous System Diseases +1

Start: 2026-03-01End: 2026-06-30Target: 34Updated: 2026-03-16

Phase 3

Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke

CompletedNCT01790997

Dexa Medica GroupAcute Ischemic Stroke

Start: 2012-05-31End: 2013-12-31Updated: 2014-06-04

DLBS1033 for the Treatment of Acute Ischemic Stroke

TerminatedNCT02362984

Dexa Medica GroupAcute Ischemic Stroke

Start: 2014-10-31End: 2017-04-30Updated: 2017-05-04

Phase 4

Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus

CompletedNCT01865474

Dexa Medica GroupType 2 Diabetes Mellitus

Start: 2013-05-31End: 2016-06-30Updated: 2016-08-04

Comparing Oral Lumbrokinase DLBS1033 and Betahistine Mesylate in Benign Paroxysmal Positional Vertigo

CompletedNCT07075289

Universitas Sebelas MaretBenign Paroxysmal Positional Vertigo (Disorder)

Start: 2024-04-01End: 2024-12-27Updated: 2025-07-20

Unknown Phase

Safety and Efficacy of DLBS1033 in Healthy Subjects

CompletedNCT01378585

Dexa Medica GroupHealthy

Start: 2011-05-31End: 2011-07-31Updated: 2012-08-23

DLBS1033 as Adjunctive Therapy for Patients With Diabetic Neuropathy

Not yet recruitingNCT07683598

RS H Adam MalikDiabetic Neuropathy

Start: 2026-08-01End: 2027-03-01Target: 80Updated: 2026-07-06

Related Papers

Role of DLBS1033 in the management of acute ischemic stroke patients: study protocol for a randomized controlled study

Asia Pacific Clinical and Translational Nervous System Diseases2016-01-012 citations